VC
TMO icon

Vicus Capital’s Thermo Fisher Scientific TMO Stock Holding History

Vicus Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-343
Closed -$212K – 253
2024
Q3 		$212K Sell
343
-499
-59% -$295K 0.02% 208
2024
Q2 		$465K Buy
842
+66
+9% +$37.8K 0.04% 167
2024
Q1 		$451K Buy
+776
New +$435K 0.04% 164
2023
Q4 		– Sell
-679
Closed -$344K – 255
2023
Q3 		$344K Buy
+679
New +$362K 0.04% 182
2021
Q2 		– Sell
-514
Closed -$235K – 233
2021
Q1 		$235K Buy
514
+14
+3% +$6.68K 0.03% 210
2020
Q4 		$233K Buy
+500
New +$234K 0.03% 203

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vicus Capital's TMO Position: Q4 2024 in Review

Vicus Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 343 shares — an estimated $212K sold.

Vicus Capital first reported a position in TMO in Q4 2020 and held it in 6 quarters. The position peaked at $465K in Q2 2024. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Vicus Capital reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Vicus Capital sold 343 Thermo Fisher Scientific shares in Q4 2024, an estimated $212K.
  • Vicus Capital first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 6 quarters.
  • Vicus Capital's Thermo Fisher Scientific position peaked at $465K in Q2 2024.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Vicus Capital's 13F filing for Q4 2024, filed 30 Jan 2025.